Author: admin

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, whether he plans to bring forward legislation to regulate cosmetic surgery.

    Ben Gummer

    All medical doctors, including those carrying out cosmetic surgery, must register with the General Medical Council, hold a license to practise and meet set professional standards to work in the United Kingdom.

    We want to raise the standards of care in the cosmetics industry so patients can feel confident they are getting the best care from highly-qualified professionals. There are examples of high-quality cosmetic interventions provided by trained staff to high standards of care and satisfaction. The Department and its delivery partners have implemented a range of non-regulatory actions which we are reviewing and monitoring before confirming whether new legislation would add significant value to safeguards for people choosing cosmetic procedures.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on the prevention of still births.

    Ben Gummer

    Since May 2015, Ministers at the Department have not held any meetings with the Royal Colleges to specifically discuss the prevention of stillbirths. However, the Department has been working in partnership with Sands (the Stillbirth and Neonatal Death charity) and a range of key organisations, including NHS England, Public Health England, the Royal College of Midwives and the Royal College of Obstetricians and Gynaecologists, to drive forward a stillbirth prevention work programme.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, by when he plans for new drug treatments for sepsis and Acute Respiratory Disease Syndrome to be available on the NHS.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) is currently developing a clinical guideline on the recognition, diagnosis and management of severe sepsis. The guideline will consider the full range of treatment options for sepsis. NICE currently plans to publish this guidance in July 2016.

    There are no plans for NICE to develop technology appraisal guidance on the use of new drug treatments for sepsis or acute respiratory distress syndrome (ARDS).

    NHS England has advised that there have been many trials of new treatments for ARDS but no consistent benefit has been found in any of these.

    In the absence of NICE guidance, funding decisions for individual treatments should be made by the relevant National Health Service commissioner, based on an assessment of the available evidence. Commissioners are also required to have processes in place for the consideration of exceptional funding requests.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, if he will make available on the NHS cyber-knife technology to treat cancer and reduce time spent in hospital by cancer patients.

    Jane Ellison

    Cyber-knife technology is one of three treatment platforms that can be used to treat a number of cancers, together with some benign conditions. The treatment platforms deliver stereotactic radiotherapy, both to the body (stereotactic ablative body radiotherapy) which is commissioned for the treatment of non-small cell lung cancer, and to the head (stereotactic radiosurgery/radiotherapy) for a range of cancer indications covered by clinical commissioning policies which can be found at:

    www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d05/

    It should be noted that NHS England commissions on the basis of clinical indication and not specifically for treatment platforms. The choice of treatment platform used is ultimately a decision made by trusts themselves.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, what criteria are applied for the use of intraoperative radiotherapy for treating cancer by the NHS.

    Jane Ellison

    NHS England does not currently commission intraoperative radiotherapy for the treatment of cancer. To date it has been undertaken in a small number of centres in England as part of a clinical trial.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

    To ask the Secretary of State for Health, how many people have been diagnosed with liver disease in each of the last five years.

    Jane Ellison

    Information is not available in the format requested.

  • Robert Neill – 2015 Parliamentary Question to the Department of Health

    Robert Neill – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Robert Neill on 2015-10-19.

    To ask the Secretary of State for Health, for what reasons his recent assessment of NHS England’s performance against the Mandate in 2014-15 did not address NHS England’s performance in meeting the requirement contained in the Mandate to ensure that people have access to the right treatment when they need it.

    George Freeman

    The Secretary of State’s annual assessment of NHS England’s performance in 2014-15 sets out specifically his evaluation of NHS England’s performance in meeting the access standards set out in the NHS Constitution.

    In addition, the Secretary of State’s annual assessment sets out that he agrees with NHS England’s own assessment, as set out in its annual report for 2014-15, that it has made good progress against delivering its objectives in the mandate, which includes ensuring that people have the right treatment when they need it.

  • Robert Neill – 2015 Parliamentary Question to the Department of Health

    Robert Neill – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Robert Neill on 2015-10-19.

    To ask the Secretary of State for Health, what information his Department holds on when the Health and Social Care Information Centre expects its innovation scorecard to attain the status of non-experimental statistics; what steps that centre is taking to improve the data quality of that scorecard; and if he will make a statement.

    George Freeman

    The Health and Social Care Information Centre is working towards the removal of the experimental status of the innovation scorecard during the first half of 2016. The data already complies with the UK Statistics Authority’s Code of Practice for Official Statistics.

  • Robert Neill – 2015 Parliamentary Question to the Department of Health

    Robert Neill – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Robert Neill on 2015-10-19.

    To ask the Secretary of State for Health, in which months the implementation of commitments to increase access to treatments contained in the Pharmaceutical Price Regulation Scheme has been discussed in NHS England accountability meetings.

    George Freeman

    Improving patients’ access to innovative, National Institute for Health and Care Excellence approved treatments is part of an objective set out in the Government’s mandate to NHS England. Performance against the mandate is discussed in NHS England accountability meetings chaired by the Secretary of State. The minutes of the meetings are published on the Government’s website at:

    https://www.gov.uk/government/publications/nhs-commissioning-board-accountability-meeting-minutes

  • Greg Knight – 2015 Parliamentary Question to the Department of Health

    Greg Knight – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Greg Knight on 2015-10-19.

    To ask the Secretary of State for Health, how much the NHS has spent on the treatment of non-UK nationals in each of the last five years for which figures are available.

    Alistair Burt

    The Health and Social Care Information Centre’s hospital episode statistics do not contain information about the patient’s residency, nationality or migration status; therefore it is not possible to provide the cost to the National Health Service of providing treatment to non-United Kingdom nationals as requested.